| Literature DB >> 32145891 |
Aarthi S Reddy1, Domingo E Uceda1, Mina Al Najafi1, Amit K Dey1, Nehal N Mehta2.
Abstract
Fluorodeoxyglucose-PET/computed tomography combines the high sensitivity of PET with the excellent spatial resolution provided by computed tomography, making it a potentially powerful tool for capturing and quantifying early vascular diseases. Patients with chronic inflammatory states have an increased risk of cardiovascular events; there is also increased vascular fluorodeoxyglucose uptake seen compared with healthy controls. This review examines the use of fluorodeoxyglucose-PET/computed tomography in assessing low-grade vascular inflammation in chronic inflammation and then reviews fluorodeoxyglucose-PET/computed tomography as a tool in monitoring the efficacy of various treatments known to modulate cardiovascular disease. Published by Elsevier Inc.Entities:
Keywords: Fluorodeoxyglucose-positron emission tomography/computed tomography; Inflammation; Vascular disease
Mesh:
Substances:
Year: 2020 PMID: 32145891 PMCID: PMC7668223 DOI: 10.1016/j.cpet.2019.11.009
Source DB: PubMed Journal: PET Clin ISSN: 1556-8598